New Drug Causes 20 Percent Weight Loss in Early Amgen Results
The pharmaceutical manufacturer Amgen announced on Tuesday that an experimental obesity drug helped patients lose up to 20 percent of their weight in a year. The drug, MariTide, is given by injection once a month, compared with once a week for other obesity drugs like Wegovy and Zepbound that are already on the market.
Amgen stock was dropping sharply Tuesday after releasing what looked like positive data from a Phase 2 study for its ...
Amgen (AMGN) reported today the highly anticipated results of a mid-stage trial of its experimental weight loss drug and ...
Amgen released the long-awaited results from its study of weight loss injection MariTide and the results — while ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback